Skip to content

Feasibility Study of a Home Rehabilitative Network to Treat Prolonged Weaned Patients

Feasibility and Efficacy of a Home Rehabilitative Network for Prolonged Weaned Patients Discharged From a Weaning Unit

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01577927
Acronym
UTIR
Enrollment
60
Registered
2012-04-16
Start date
2011-07-31
Completion date
2013-07-31
Last updated
2014-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Diseases

Keywords

weaning, severe chronic diseases, UTIR

Brief summary

Patients at high complexity with severe chronic diseases can require several admission in intensive care units (ICU) to overcome acute exacerbations by the use of assisted ventilation. In the last 10 years, new technologies and beds in ICU evidenced a new group of patients often needing weaning procedures due to a long-lasting period of mechanical ventilation. These patients are often under chronic conditions with recurrent symptoms, reduced effort tolerance and depression. Weaning process is a frail step in the medical history of a patient who has survived an acute episode of respiratory failure and has spent a period of time under mechanical ventilation. Patients are followed for the duration of in-hospital stay, an expected average period of 4 weeks. When discharged fron an Intensive Care Unit (ICU) or a weaning center, the patient is usually managed by GPs and by the hospital where he has been admitted to following re-exacerbations. The conventional approach is for sure inadequate for this type of patient whose clinical complexity, disability and frailty need for a continuity of care through a higher complex approach of management. A structured program of Home Rehabilitation could be a possible solution to this problem. Thus, the hypothesis of the study is to evaluate feasibility and sustainability and efficacy of a home rehabilitative network for prolonged weaned patients discharged from a weaning unit.

Detailed description

Patients referred to the Fondazione Salvatore Maugeri for prolonged weaning are enrolled and trained in an individualised program of home care in order to recover their own autonomies. Home care compares 2 arms: usual care vs physiotherapist (PT)-assisted care. Usual care consists in supporting drug and oxygen therapy, mechanical ventilation, GP's assistance, periodical in-hospital visit. The PT-assisted home care is supported by PT at least 2 times/month, autonomous 50 min physical activity/working day by the help of a DVD. The physical activity consists in cyclette, calisthenic exercises, and training of the respiratory muscles. Few brief educational lessons by PT preceded the training activity. Every two weeks, PT calls the patient by phone for an educational reinforcement.

Interventions

OTHERUsual home care

Usual home care consists in supporting drug and oxygen therapy, mechanical ventilation, GP's assistance,and periodical in-hospital visit.

BEHAVIORALPT-assisted home rehabilitation

Patient performs 50 min physical activity/working day autonomously by the help of a DVD. The physical activity consists in cyclette, calisthenic exercises, and training of the respiratory muscles. Every two weeks, PT phones the patient for an educational reinforcement.

Sponsors

Fondazione Salvatore Maugeri
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* General Inclusion criteria: 1. Signature of the informed 2. Good expectation of life * Specific Inclusion Criteria : Score of general dependences \< 19 according to the Critical Patients Autonomy Planning (CPAP) Scale

Exclusion criteria

* Patient with neuromuscular, highly progressive neurological diseases (i.e. amyotrophic lateral sclerosis), patient requiring surgical interventions, sedation, and hemodialysis. * Unstable patient conditions as daily variability of the blood arterial pressure \>20%, arrhythmias, PaO2/FiO2 \< 300, unsatisfactory respiratory pattern, haemoglobin \< 7 g /dL, temperature \> 38°C, presence of neurological or orthopaedic side effects, and recent embolisms from TVP. Refusal.

Design outcomes

Primary

MeasureTime frameDescription
Critical Patients Autonomy Planning (CPAP)Changes from baseline and 4 weeks, and 6 months after home activityCPAP is a measure of dependency. CPAP was evaluated at three different time-points: at in-hospital admission (baseline), at discharge (patients are followed for the duration of their in-hospital stay, an expected average time of 4 weeks), and after 6 months of physical activity at home.

Secondary

MeasureTime frameDescription
Barthel IndexChanges from baseline and 4 weeks, and 6 months after home activityMeasure of dependency.
Maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP)Changes from baseline and 4 weeks (average time), and 6 months after home activityRespiratory Functionality
MRF 26Changes between discharge at 4 weeks (average time) and 6 months after home activityQuality of life evaluation.
Likert ScaleChanges between discharge at 4 weeks (average time) and 6 months after home activitySatisfaction for patient/caregiver
Gussago Nursing ScaleChanges from baseline and 4 weeks, and 6 months after home activityMeasure of dependency.
MRC Scale and/or dynamometerChanges between baseline, discharge at 4 weeks, and 6 months after home activityRehabilitative measure referring to muscles force
6-min walking testChanges from baseline and discharge at 4 weeks, and 6 months after home activityRehabilitative measure evaluating the effort tolerance.
EuroQolChanges between discharge at 4 weeks (average time) and 6 months after home activityQuality of life evaluation
Pre-morbidity life-style (PLS)Changes from baseline and 4 weeks, and 6 months after home activityMeasure of dependency.
MortalityChanges between 3, 6 and 12 months post-dischargeClinical measure

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026